for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Cognex Corporation

CGNX.O

Latest Trade

84.37USD

Change

-0.81(-0.95%)

Volume

453,757

Today's Range

83.76

 - 

84.65

52 Week Range

35.20

 - 

88.15

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
85.18
Open
84.34
Volume
453,757
3M AVG Volume
15.43
Today's High
84.65
Today's Low
83.76
52 Week High
88.15
52 Week Low
35.20
Shares Out (MIL)
174.63
Market Cap (MIL)
14,875.22
Forward P/E
81.38
Dividend (Yield %)
0.28

Next Event

Q4 2020 Cognex Corp Earnings Release

Latest Developments

More

Cognex Declares Very Special Cash Dividend Of $2 Per Share

Cognex Posts Adjusted Earnings Per Share $0.47

Cognex Increases Quarterly Cash Dividend

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Cognex Corporation

Cognex Corporation (Cognex) is a provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. The Company operates through the machine vision technology segment. The Company's machine vision products are used to automate the manufacture and tracking of discrete items, such as mobile phones, aspirin bottles and automobile tires, by locating, identifying, inspecting and measuring them during the manufacturing or distribution process. The Company's products include vision software, vision systems, vision sensors and identification (ID) products. Its products range from vision sensors that are integrated, to personal computer (PC)-based systems for users. Its products also have a range of physical forms, depending upon the user's need. Cognex sells its products through a direct sales force, as well as through a global network of integration and distribution partners.

Industry

Scientific & Technical Instr.

Contact Info

1 Vision Dr

NATICK, MA

01760-2083

United States

+1.508.6503000

https://www.cognex.com/

Executive Leadership

Robert J. Shillman

Chairman of the Board, Chief Culture Officer

Robert J. Willett

President, Chief Executive Officer, Director

Paul D. Todgham

Chief Financial Officer, Senior Vice President - Finance, Principal Financial Officer and Principal Accounting Officer

Sheila Marie DiPalma

Senior Vice President of Employee Services

Anthony Sun

Lead Independent Director

Key Stats

2.94 mean rating - 18 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

0.7K

2018

0.8K

2019

0.7K

2020(E)

0.8K
EPS (USD)

2017

1.450

2018

1.240

2019

0.810

2020(E)

1.047
Price To Earnings (TTM)
80.25
Price To Sales (TTM)
19.65
Price To Book (MRQ)
9.88
Price To Cash Flow (TTM)
69.49
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
11.59
Return on Equity (TTM)
10.85

Latest News

Latest News

FDA declines to approve Pain Therapeutics' opioid drug, shares plunge

The U.S. Food and Drug Administration declined to approve Pain Therapeutics Inc's abuse-deterrent opioid treatment Remoxy for the fourth time, sending the company's shares down 35 percent to a record low.

BRIEF-Cognex Corp Reports Qtrly GAAP EPS Of $0.21

* REVENUE FOR Q2-18 IS EXPECTED TO BE BETWEEN $200 MILLION AND $210 MILLION

BRIEF-Cognex Q4 Revenue Rose 39 Percent

* REVENUE FOR Q1-18 IS EXPECTED TO BE BETWEEN $165 MILLION AND $175 MILLION

BRIEF-Cognex Authorizes New Stock Buyback Program

* COGNEX CORP - BOARD AUTHORIZED PURCHASE OF UP TO $150 MILLION OF COGNEX COMMON STOCK

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up